Surgical site infections after coronary artery bypass surgery, with special reference to antibiotic prophylaxis and risk factors.
Vuorisalo
S
S
Department of Surgery, University of Oulu, Finland. sailaritta.vuorisalo@fimnet.fi
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D002444:Cefuroxime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors; D013530:Surgical Wound Infection / Q000517:prevention & control*; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D014640:Vancomycin; D002444:Cefuroxime